Safety and immunogenicity of GMZ2 - a MSP3-GLURP fusion protein malaria vaccine candidate.
Esen M, Kremsner PG, Schleucher R, Gässler M, Imoukhuede EB, Imbault N, Leroy O, Jepsen S, Knudsen BW, Schumm M, Knobloch J, Theisen M, Mordmüller B.
Esen M, et al. Among authors: schleucher r.
Vaccine. 2009 Nov 16;27(49):6862-8. doi: 10.1016/j.vaccine.2009.09.011. Epub 2009 Sep 13.
Vaccine. 2009.
PMID: 19755144
Clinical Trial.